Stockreport

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss [CNBC]

Valneva SE - American Depositary Shares  (VALN) 
PDF Fhm | Moment | Getty Images Pfizer on Monday said it will seek regulatory approval for a Lyme disease vaccine candidate despite the shot failing a late-stage trial. [Read more]